Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | C5AR1 | P21730 | 3/20 | 0.62 |
| ▸ | CA12 | O43570 | 1/20 | 0.47 |
| ▸ | CA9 | Q16790 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | KEAP1 | Q14145 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | MCOLN3 | Q8TDD5 | 1/20 | 0.43 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.42 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.41 |
| ▸ | HTT | P42858 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7150548 | 0.86 | C5AR1 (0.83) | C5AR1CA12CA9LMNATSHR | |
| SCHEMBL13649261 | 0.86 | C5AR1 (0.65) | C5AR1CA12CA9LMNATSHR | |
| SCHEMBL17174226 | 0.83 | C5AR1 (0.62) | C5AR1CA12CA9LMNATSHR | |
| SCHEMBL15756100 | 0.83 | C5AR1 (0.62) | C5AR1CA12CA9LMNATSHR | |
| SCHEMBL25920653 | 0.83 | C5AR1 (0.62) | C5AR1CA12CA9LMNATSHR | |
| SCHEMBL17174232 | 0.81 | KEAP1 (0.70) | C5AR1LMNAKEAP1MCOLN3CYP2C9 | |
| SCHEMBL4611036 | 0.81 | C5AR1 (0.57) | C5AR1CA12CA9LMNAKEAP1 | |
| SCHEMBL17174225 | 0.80 | C5AR1 (0.57) | C5AR1CA12CA9LMNATSHR | |
| SCHEMBL17174229 | 0.80 | C5AR1 (0.57) | C5AR1CA12CA9LMNATSHR | |
| SCHEMBL17174230 | 0.78 | RAB9A (0.58) | C5AR1LMNAHTTNPSR1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150291517-A1 | BENZENESULFONAMIDE COMPOUNDS FOR SOMATIC EMBRYOGENESIS IN PLANTS | STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK (NL) | 2015-10-15 | — | — | US | disclosed |
| US-20150291517-A1 | BENZENESULFONAMIDE COMPOUNDS FOR SOMATIC EMBRYOGENESIS IN PLANTS | STICHTING DIENST LANDBOUWKUNDIG ONDERZOEK (NL) | 2015-10-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150291517-A1 | BENZENESULFONAMIDE COMPOUNDS FOR SOMATIC EMBRYOGENESIS IN PLANTS | KCNJ2, HCN2, HACL2 | C5AR1 4657/4885CA12 3085/4885CA9 3523/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.